Paper Overview
- Field: Machine Learning
- Authors: Anonymous
- Published: 2026-03-06
- arXiv: 2603.05501
Abstract
Estimating heterogeneous treatment effects (HTEs) from right-censored survival data is critical in high-stakes applications such as precision medicine and individualized policy-making. Yet, the survival analysis setting poses unique challenges for HTE estimation due to censoring, unobserved counterfactuals, and complex identification assumptions.
The authors introduce SurvHTE-Bench, the first comprehensive benchmark for HTE estimation with censored outcomes. The benchmark spans:
1. A modular suite of synthetic datasets with known ground truth 2. Semi-synthetic datasets that pair real-world covariates with simulated treatments and outcomes 3. Real-world datasets from a twin study and from an HIV clinical trial
Background
Survival analysis introduces distinctive difficulties for treatment effect estimation that standard HTE benchmarks do not capture: outcomes may be right-censored, counterfactual outcomes are unobserved, and valid inference relies on complex identification assumptions. A dedicated benchmark enables fair, reproducible evaluation of methods designed for this setting.
---
*Collected automatically on 2026-03-07.*